Building a Globally Scalable Specialty Pharma Brand from India

Talking to Pharma Industrial India, Nikkhil K. Masurkar, CEO, ENTOD Pharmaceuticals, discusses the company’s innovation-led growth strategy and its mission to transform ophthalmic, ENT and dermatology care through advanced research and technology integration. From pioneering AI-driven formulation design and robotic sterile manufacturing to developing breakthrough therapies in myopia, presbyopia and ocular surface diseases, he outlines how ENTOD is shaping future of specialty pharmaceuticals.